Preventing Periprosthetic Joint Infection

US Musculoskeletal Review, 2011;6(1):8-10

Abstract

Total joint arthroplasty (TJA) is one of the most commonly performed orthopaedic operations today. While extremely successful in the majority of cases, perhaps the most feared complication of TJA is periprosthetic joint infection (PJI). PJI causes a substantial burden to the patient as well as a great economic strain to the healthcare system. It is imperative that orthopaedic surgeons take every step possible in order to minimize the chance of PJI. Topics requiring attention include: host optimization, skin decontamination, use of prophylactic antibiotics, the operating room environment, surgical set up and technique, and post-operative care. Pre-operative methicillin-resistant Staphylococcus aureus (MRSA) screening and decolonization has been receiving much research interest and could become a popular step in preventing PJI in the future. While there has been a substantial decline in the incidence of PJI, it is likely to remain an important problem in orthopaedics.
Keywords
Total joint arthroplasty, periprosthetic joint infection, prevention
Disclosure The authors have no conflicts of interest to declare.
Received: May 06, 2011 Accepted July 07, 2011
Correspondence: Javad Parvizi, MD, FRCS, Department of Orthopaedic Surgery, Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, 925 Chestnut St, Philadelphia, PA 19107. E: parvj@aol.com

Total joint arthroplasty (TJA) is one of the most commonly performed orthopaedic operations today. There were over 600,000 performed in the US in 2003, and that number is thought to now be over 1,000,000 per year.1

While extremely successful in the majority of patients, TJA is not without the risk for complications. Perhaps the most devastating is periprosthetic joint infection (PJI), seen in 1–2% of arthroplasties.2 Infection is the most common reason for revision knee arthroplasty,3–6 which inflicts a substantial burden on the patient and a great economic strain to the healthcare system.7–10

Undoubtedly, the best way to decrease the burden of infection is to prevent the infection from occurring. One of the most critical steps in prevention is recognition of the fact that most infections arise from contamination intraoperatively. Hence, multiple steps can be taken to minimize the chance of contamination throughout TJA surgery. By remaining cognizant of possible sources of contamination and taking all necessary precautions, the orthopaedic surgeon can minimize the chances of PJI after TJA. This article aims to share strategies for preventing PJI, including some of the authors’ own practices. It concludes with some exciting areas of research on the horizon.

Prevention Strategies
Host Optimization
Multiple associations and risk factors are known for PJI, including but not limited to: systemic malignancy, prior joint arthroplasty, rheumatoid arthritis, skin ulcers, obesity, recurrent urinary tract infections (UTIs), use of oral corticosteroids or immunosuppressive therapy, poor nutrition, hypokalemia, diabetes, and history of smoking.11–13 It is of utmost importance to optimize the factors that can be controlled prior to joint arthroplasty. This includes resolution of any possible nidus of infection such as superficial skin infections, ulcerations, periodontal disease, or existing UTI. In addition, our institution requires smoking cessation prior to surgery, as the effects of smoking on wound healing and infection are well-known.14

While is it known that diabetics are more prone to PJI, it is unclear if steps can be taken to decrease this risk. Is the infectious risk due to the long-term effects of hyperglycemia or to the more acute effects of perioperative hyperglycemia? Studies in other surgical disciplines are beginning to point towards the latter, with improved outcomes being obtained through strict control of perioperative blood glucose.15,16 In one study, tight glucose control was shown to decrease deep sternal wound infection rates in diabetics to the rates of non-diabetics in a cohort of diabetic patients undergoing cardiac surgery.15 This is an area that certainly warrants future investigation, specifically in joint arthroplasty patients. Regardless, it is clear that perioperative diabetic management is beneficial.

References:
  1. Kurtz S, Ong K, Lau E, et al., Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030, J Bone Joint Surg Am, 2007;89(4):780–5.
  2. Kurtz SM, Lau E, Schmier J, et al., Infection burden for hip and knee arthroplasty in the United States, J Arthroplasty, 2008;23(7):984–1.
  3. Sharkey PF, Hozack WJ, Rothman RH, et al., Insall Award paper. Why are total knee arthroplasties failing today?, Clin. Orthop Relat. Res, 2002;(404):7–13.
  4. Clohisy JC, Calvert G, Tull F, et al., Reasons for revision hip surgery: a retrospective review, Clin Orthop Relat Res, 2004;(429):188–92.
  5. Vessely MB, Whaley AL, Harmsen WS, et al., The Chitranjan Ranawat Award: Long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties, Clin Orthop Relat Res, 2006;452:28–34.
  6. Mortazavi SMJ, Molligan J, Austin MS, et al., Failure following revision total knee arthroplasty: infection is the major cause, Int Orthop, 2010; (Epub ahead of print).
  7. Sculco TP, The economic impact of infected joint arthroplasty, Orthopedics, 1995;18(9):871–3.
  8. Bozic KJ, Ries MD, The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization, J Bone Joint Surg Am, 2005;87(8):1746–51.
  9. Kurtz SM, Ong KL, Schmier J, et al., Future clinical and economic impact of revision total hip and knee arthroplasty, J Bone Joint Surg Am, 2007;89(Suppl. 3):144–51.
  10. Parvizi J, Pawasarat IM, Azzam KA, et al., Periprosthetic joint infection: the economic impact of methicillin-resistant infections, J Arthroplasty, 2010;25(Suppl. 6):103–07.
  11. Wilson MG, Kelley K, Thornhill TS, Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases, J Bone Joint Surg Am, 1990;72(6):878–83.
  12. Berbari EF, Hanssen AD, Duffy MC, et al., Risk factors for prosthetic joint infection: case-control study, Clin Infect Dis, 1998;27(5):1247–54.
  13. Peersman G, Laskin R, Davis J, Peterson M, Infection in total knee replacement: a retrospective review of 6489 total knee replacements, Clin Orthop Relat Res, 2001;(392):15–23.
  14. Kean J, The effects of smoking on the wound healing process, J Wound Care, 2010;19(1):5–8.
  15. Furnary AP, Wu Y, Bookin SO, Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project, Endocr Pract, 2004;10 Suppl. 2:21–33.
  16. Furnary AP, Wu Y, Eliminating the diabetic disadvantage: the Portland Diabetic Project, Semin Thorac Cardiovasc Surg, 2006;18(4):302–8.
  17. Gherini S, Vaughn BK, Lombardi AV, Mallory TH, Delayed wound healing and nutritional deficiencies after total hip arthroplasty, Clin Orthop Relat Res, 1993;(293):188–95.
  18. Marín LA, Salido JA, López A, Silva A, Preoperative nutritional evaluation as a prognostic tool for wound healing, Acta Orthop Scand, 2002;73(1):2–5.
  19. Markovic TP, Natoli SJ, Paradoxical nutritional deficiency in overweight and obesity: the importance of nutrient density, Med J Aust, 2009;190(3):149–51.
  20. Gil-Egea MJ, Pi-Sunyer MT, Verdaguer A, et al., Surgical wound infections: prospective study of 4,468 clean wounds, Infect Control, 1987;8(7):277–80.
  21. Seropian R, Reynolds BM, Wound infections after preoperative depilatory versus razor preparation, Am J Surg, 1971;121(3):251–4.
  22. Prokuski L, Prophylactic antibiotics in orthopaedic surgery, J Am Acad Orthop Surg, 2008;16(5):283–93.
  23. Fitzgerald RH, Thompson RL, Cephalosporin antibiotics in the prevention and treatment of musculoskeletal sepsis, J Bone Joint Surg Am, 1983;65(8):1201–5.
  24. Ip D, Yam SK, Chen CK, Implications of the changing pattern of bacterial infections following total joint replacements, J Orthop Surg (Hong Kong), 2005;13(2):125–30.
  25. Parvizi J, Azzam K, Ghanem E, et al., Periprosthetic infection due to resistant staphylococci: serious problems on the horizon, Clin Orthop Relat Res, 2009;467(7):1732–9.
  26. Meehan J, Jamali AA, Nguyen H, Prophylactic antibiotics in hip and knee arthroplasty, J Bone Joint Surg Am, 2009;91(10):2480–90.
  27. Ritter MA, Eitzen H, French ML, Hart JB, The operating room environment as affected by people and the surgical face mask, Clin Orthop Relat Res, 1975;(111):147–50.
  28. Bethune DW, Blowers R, Parker M, Pask EA, Dispersal of Staphylococcus aureus by patients and surgical staff, Lancet, 1965;1(7383):480–3.
  29. Ritter MA, Operating room environment, Clin Orthop Rela Res, 1999;(369):103–9.
  30. McCue SF, Berg EW, Saunders EA, Efficacy of double-gloving as a barrier to microbial contamination during total joint arthroplasty, J Bone Joint Surg Am, 1981;63(5):811–3.
  31. Ritter MA, French ML, Eitzen H, Evaluation of microbial contamination of surgical gloves during actual use, Clin Orthop Relat Res, 1976;(117):303–6.
  32. Chosky SA, Modha D, Taylor GJ, Optimisation of ultraclean air. The role of instrument preparation, J Bone Joint Surg Br, 1996;78(5):835–7.
  33. Baird RA, Nickel FR, Thrupp LD, et al., Splash basin contamination in orthopaedic surgery, Clin Orthop Relat Res, 1984;(187):129–33.
  34. Greenough CG, An investigation into contamination of operative suction, J Bone Joint Surg Br, 1986;68(1):151–3.
  35. Strange-Vognsen HH, Klareskov B, Bacteriologic contamination of suction tips during hip arthroplasty, Acta Orthop Scand, 1988;59(4):410–1.
  36. Parvizi J, Saleh KJ, Ragland PS, et al., Efficacy of antibioticimpregnated cement in total hip replacement, Acta Orthop, 2008;79(3):335–41.
  37. Cummins JS, Tomek IM, Kantor SR, et al., Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty, J Bone Joint Surg Am, 2009;91(3):634–41.
  38. Parvizi J, Ghanem E, Joshi A, et al., Does "excessive" anticoagulation predispose to periprosthetic infection?, J Arthroplasty, 2007;22(6 Suppl. 2):24–8.
  39. Kim DH, Spencer M, Davidson SM, et al., Institutional prescreening for detection and eradication of methicillinresistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery, J Bone Joint Surg Am, 2010;92(9):1820–6.